{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:52:30Z","timestamp":1791827550921,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10072-026-09322-8","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:48:16Z","timestamp":1787795296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic accuracy of plasma p-tau217 against amyloid PET: A meta-analysis of technical platform variability and ratio versus single marker comparisons"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0380-0988","authenticated-orcid":false,"given":"Chao","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"issue":"1","key":"9322_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/JAD-2009-0960","volume":"16","author":"HC Huang","year":"2009","unstructured":"Huang HC, Jiang ZF (2009) Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer\u2019s disease. J Alzheimers Dis 16(1):15\u201327","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"9322_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1590\/S1980-57642009DN30300003","volume":"3","author":"VJR de Paula","year":"2009","unstructured":"de Paula VJR, Guimar\u00e3es FM, Diniz BS, Forlenza OV (2009) Neurobiological pathways to Alzheimer\u2019s disease: amyloid-beta, TAU protein or both? Dement Neuropsychol 3(3):188\u2013194","journal-title":"Dement Neuropsychol"},{"issue":"5","key":"9322_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","volume":"3","author":"O Hansson","year":"2023","unstructured":"Hansson O, Blennow K, Zetterberg H, Dage J (2023) Blood biomarkers for Alzheimer\u2019s disease in clinical practice and trials. Nat Aging 3(5):506\u2013519","journal-title":"Nat Aging"},{"key":"9322_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.dadm.2017.04.002","volume":"8","author":"E Carro","year":"2017","unstructured":"Carro E, Bartolom\u00e9 F, Bermejo-Pareja F et al (2017) Early diagnosis of mild cognitive impairment and Alzheimer\u2019s disease based on salivary lactoferrin. Alzheimers Dement (Amst) 8:131\u2013138","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"9322_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3233\/JAD-170128","volume":"61","author":"JD Doecke","year":"2018","unstructured":"Doecke JD, Rembach A, Villemagne VL et al (2018) Concordance between cerebrospinal fluid biomarkers with Alzheimer\u2019s disease pathology between three independent assay platforms. J Alzheimers Dis 61(1):169\u2013183","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"9322_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221365","volume":"14","author":"EG M\u00fcller","year":"2019","unstructured":"M\u00fcller EG, Edwin TH, Stokke C et al (2019) Amyloid-\u03b2 PET-correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer\u00b4s disease diagnosis in a memory clinic. PLoS One 14(8):e0221365","journal-title":"PLoS One"},{"issue":"3","key":"9322_CR7","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/brain\/awad330","volume":"147","author":"S De Meyer","year":"2024","unstructured":"De Meyer S, Blujdea ER, Schaeverbeke J et al (2024) Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes. Brain 147(3):936\u2013948","journal-title":"Brain"},{"issue":"1","key":"9322_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01087-4","volume":"14","author":"J Traub","year":"2022","unstructured":"Traub J, Otto M, Sell R et al (2022) Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients. Alzheimers Res Ther 14(1):149","journal-title":"Alzheimers Res Ther"},{"key":"9322_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.900773","volume":"14","author":"W Qin","year":"2022","unstructured":"Qin W, Li F, Jia L et al (2022) Phosphorylated tau 181 serum levels predict Alzheimer\u2019s disease in the preclinical stage. Front Aging Neurosci 14:900773","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"9322_CR10","doi-asserted-by":"publisher","first-page":"e14621","DOI":"10.1002\/alz.14621","volume":"21","author":"NJ Ashton","year":"2025","unstructured":"Ashton NJ, Benedet AL, Molfetta GD et al (2025) Biomarker discovery in Alzheimer\u2019s and neurodegenerative diseases using Nucleic Acid Linked Immuno-Sandwich Assay. Alzheimers Dement 21(5):e14621","journal-title":"Alzheimers Dement"},{"issue":"12","key":"9322_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70931","volume":"21","author":"M Daniilidou","year":"2025","unstructured":"Daniilidou M, \u00d6hlund-Wistbacka U, Hagman G et al (2025) Enhancing diagnostic precision in Alzheimer\u2019s disease: impact of comorbidities on blood biomarkers for clinical integration. Alzheimers Dement 21(12):e70931","journal-title":"Alzheimers Dement"},{"issue":"11","key":"9322_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70942","volume":"21","author":"YH Um","year":"2025","unstructured":"Um YH, Wynveen P, Holland M et al (2025) Neuroimaging correlates and biomarker performance of a fully automated plasma p-tau217\/A\u03b242 ratio assay in a clinical cohort with Alzheimer\u2019s disease. Alzheimers Dement 21(11):e70942","journal-title":"Alzheimers Dement"},{"issue":"11","key":"9322_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70867","volume":"21","author":"C Delaby","year":"2025","unstructured":"Delaby C, Gabelle A, Duchiron M et al (2025) Impact of preanalytical delay on the performance of plasma A\u03b242, A\u03b242\/40, p-tau217, and p-tau217\/A\u03b242 in detecting brain amyloidosis in the ALZAN cohort. Alzheimers Dement 21(11):e70867","journal-title":"Alzheimers Dement"},{"key":"9322_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105741","volume":"116","author":"A Gonz\u00e1lez-Escalante","year":"2025","unstructured":"Gonz\u00e1lez-Escalante A, Mil\u00e0-Alom\u00e0 M, Brum WS et al (2025) A plasma biomarker panel for detecting early amyloid-\u03b2 accumulation and its changes in middle-aged cognitively unimpaired individuals at risk for Alzheimer\u2019s disease. EBioMedicine 116:105741","journal-title":"EBioMedicine"},{"issue":"9","key":"9322_CR15","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s43587-023-00471-5","volume":"3","author":"WS Brum","year":"2023","unstructured":"Brum WS, Cullen NC, Janelidze S et al (2023) A two-step workflow based on plasma p-tau217 to screen for amyloid \u03b2 positivity with further confirmatory testing only in uncertain cases. Nat Aging 3(9):1079\u20131090","journal-title":"Nat Aging"},{"key":"9322_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71199","author":"HK Kim","year":"2026","unstructured":"Kim HK, Lee JH, Chun JH et al (2026) Plasma p-tau217 predicts PET-based pathological staging for precision Alzheimer disease assessment. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.71199","journal-title":"Alzheimers Dement"},{"issue":"1","key":"9322_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71009","volume":"22","author":"DP Hibar","year":"2026","unstructured":"Hibar DP, Bauer A, Rabe C et al (2026) Elecsys pTau217 plasma immunoassay detection of amyloid pathology in clinical cohorts. Alzheimers Dement 22(1):e71009","journal-title":"Alzheimers Dement"},{"issue":"1","key":"9322_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00259-025-07457-y","volume":"53","author":"D Shin","year":"2025","unstructured":"Shin D, Jang H, Yoo H et al (2025) Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles. Eur J Nucl Med Mol Imaging 53(1):518\u2013530","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"9322_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01826-3","volume":"17","author":"H Kang","year":"2025","unstructured":"Kang H, Yoo H, Lee J et al (2025) Plasma phosphorylated tau 217 and amyloid\u2011\u03b2 42\/40 for amyloid risk in subgroups. Alzheimers Res Ther 17(1):184","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"9322_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70707","volume":"21","author":"JD Doecke","year":"2025","unstructured":"Doecke JD, Chenna A, Lo M et al (2025) Combining Lumipulse p-tau217 and A\u03b242\/40 as confirmatory tests for A\u03b2 positivity prior to disease-modifying therapy. Alzheimers Dement 21(9):e70707","journal-title":"Alzheimers Dement"},{"issue":"8","key":"9322_CR21","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/s43587-025-00904-3","volume":"5","author":"G Lan","year":"2025","unstructured":"Lan G, Wang M, Gonzalez-Ortiz F et al (2025) Comprehensive evaluation of plasma tau biomarkers for detecting and monitoring Alzheimer\u2019s disease in a multicenter and multiethnic aging population. Nat Aging 5(8):1601\u20131618","journal-title":"Nat Aging"},{"issue":"8","key":"9322_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70469","volume":"21","author":"KAQ Cousins","year":"2025","unstructured":"Cousins KAQ, Korecka M, Wan Y et al (2025) Comparison of plasma p-tau217\/A\u03b242, p-tau217, and A\u03b242\/A\u03b240 biomarkers by race to detect Alzheimer\u2019s disease. Alzheimers Dement 21(8):e70469","journal-title":"Alzheimers Dement"},{"issue":"8","key":"9322_CR23","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/jnnp-2025-335830","volume":"96","author":"J Ahn","year":"2025","unstructured":"Ahn J, Lee EH, Yoo H et al (2025) Tailoring thresholds for interpreting plasma p-tau217 levels. J Neurol Neurosurg Psychiatry 96(8):722\u2013727","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"9322_CR24","first-page":"e70139","volume":"17","author":"ME Hodsdon","year":"2025","unstructured":"Hodsdon ME, Abel A, Chambers A et al (2025) Clinical validation of the Lilly SP-X P-tau217 assay: Performance in underrepresented cohorts. Alzheimer\u2019s & Dementia 17(3):e70139","journal-title":"Alzheimer's & Dementia"},{"issue":"7","key":"9322_CR25","doi-asserted-by":"publisher","first-page":"e70426","DOI":"10.1002\/alz.70426","volume":"21","author":"MD Rudolph","year":"2025","unstructured":"Rudolph MD, Sutphen CL, Register TC et al (2025) Evaluation of plasma p-tau217 for detecting amyloid pathology in a heterogeneous community-based cohort. Alzheimers Dement 21(7):e70426","journal-title":"Alzheimers Dement"},{"key":"9322_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105805","volume":"117","author":"S Lehmann","year":"2025","unstructured":"Lehmann S, Gabelle A, Duchiron M et al (2025) Comparative performance of plasma pTau181\/A\u03b242, pTau217\/A\u03b242 ratios, and individual measurements in detecting brain amyloidosis. EBioMedicine 117:105805","journal-title":"EBioMedicine"},{"issue":"4","key":"9322_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jagp.2024.09.015","volume":"33","author":"A Gildengers","year":"2025","unstructured":"Gildengers A, Weinstein AM, Gujral S et al (2025) Where do plasma biomarkers fit in with current Alzheimer\u2019s disease detection? Am J Geriatr Psychiatry 33(4):428\u2013437","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"9322_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-90232-8","volume":"15","author":"HS Kwon","year":"2025","unstructured":"Kwon HS, Hwang M, Koh SH et al (2025) Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients. Sci Rep 15(1):7791","journal-title":"Sci Rep"},{"issue":"2","key":"9322_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14502","volume":"21","author":"JR Chong","year":"2025","unstructured":"Chong JR, Hilal S, Tan BY et al (2025) Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular disease. Alzheimers Dement 21(2):e14502","journal-title":"Alzheimers Dement"},{"issue":"1","key":"9322_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14297","volume":"21","author":"KL Huang","year":"2025","unstructured":"Huang KL, Hsiao IT, Huang CW et al (2025) The Taiwan-ADNI workflow toward integrating plasma p-tau217 into prediction models for the risk of Alzheimer\u2019s disease and tau burden. Alzheimers Dement 21(1):e14297","journal-title":"Alzheimers Dement"},{"issue":"1","key":"9322_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14565","volume":"21","author":"YS Lin","year":"2025","unstructured":"Lin YS, Kwon HS, Lee WJ et al (2025) Cross-cultural validation of plasma p-tau217 and p-tau181 as precision biomarkers for amyloid PET positivity: an East Asian study in Taiwan and Korea. Alzheimers Dement 21(1):e14565","journal-title":"Alzheimers Dement"},{"key":"9322_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1624513","volume":"17","author":"Y Lu","year":"2025","unstructured":"Lu Y, Cui L, Huang L et al (2025) Predicting amyloid status in mild cognitive impairment: the role of semantic intrusions combined with plasma biomarkers. Front Aging Neurosci 17:1624513","journal-title":"Front Aging Neurosci"},{"key":"9322_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1660755","volume":"17","author":"Y Wang","year":"2025","unstructured":"Wang Y, Cui L, Pan FF et al (2025) Validation of the robustness of blood-based biomarkers for predicting amyloid-\u03b2 positivity in Chinese populations. Front Aging Neurosci 17:1660755","journal-title":"Front Aging Neurosci"},{"key":"9322_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105405","volume":"109","author":"A Feizpour","year":"2024","unstructured":"Feizpour A, Doecke JD, Dor\u00e9 V et al (2024) Detection and staging of Alzheimer\u2019s disease by plasma pTau217 on a high throughput immunoassay platform. EBioMedicine 109:105405","journal-title":"EBioMedicine"},{"key":"9322_CR35","first-page":"105405","volume":"109","author":"SE Schindler","year":"2024","unstructured":"Schindler SE, Petersen KK, Saef B et al (2024) Head-to-head comparison of leading blood tests for Alzheimer\u2019s disease pathology. Alzheimers Dement 109:105405","journal-title":"Alzheimers Dement"},{"issue":"9","key":"9322_CR36","doi-asserted-by":"publisher","first-page":"6506","DOI":"10.1002\/alz.14140","volume":"20","author":"DJ Figdore","year":"2024","unstructured":"Figdore DJ, Griswold M, Bornhorst JA et al (2024) Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassays. Alzheimers Dement 20(9):6506\u20136516","journal-title":"Alzheimers Dement"},{"issue":"3","key":"9322_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G et al (2024) Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurol 81(3):255\u2013263","journal-title":"JAMA Neurol"},{"issue":"1","key":"9322_CR38","first-page":"e12307","volume":"14","author":"V Dor\u00e9","year":"2022","unstructured":"Dor\u00e9 V, Doecke JD, Saad ZS et al (2022) Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer\u2019s continuum. Alzheimer\u2019s Dement 14(1):e12307","journal-title":"Alzheimer's Dement"},{"issue":"9","key":"9322_CR39","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","volume":"20","author":"EH Thijssen","year":"2021","unstructured":"Thijssen EH, La Joie R, Strom A et al (2021) Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol 20(9):739\u2013752","journal-title":"Lancet Neurol"},{"issue":"3","key":"9322_CR40","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1002\/alz.13686","volume":"20","author":"E Tsoy","year":"2024","unstructured":"Tsoy E, La Joie R, VandeVrede L et al (2024) Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer\u2019s disease and related dementias. Alzheimers Dement 20(3):2089\u20132101","journal-title":"Alzheimers Dement"},{"key":"9322_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2025.123739","volume":"478","author":"D Kjaergaard","year":"2025","unstructured":"Kjaergaard D, Simonsen AH, Stomrud E et al (2025) Combining plasma p-tau217 and cross-cultural cognitive tests to identify Alzheimer\u2019s disease in an ethnically diverse mixed memory clinic cohort. J Neurol Sci 478:123739","journal-title":"J Neurol Sci"},{"issue":"4","key":"9322_CR42","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1177\/13872877251390897","volume":"108","author":"D Imperiale","year":"2025","unstructured":"Imperiale D, Marcinn\u00f2 A, Atzori C et al (2025) Plasma pTau217\/A\u03b242 and pTau217 outperform pTau181\/A\u03b242 and pTau181 in predicting cerebrospinal fluid amyloid positivity: a real-world retrospective study. J Alzheimers Dis 108(4):1961\u20131971","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"9322_CR43","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/brain\/awae368","volume":"148","author":"A Pilotto","year":"2025","unstructured":"Pilotto A, Quaresima V, Trasciatti C et al (2025) Plasma p-tau217 in Alzheimer\u2019s disease: Lumipulse and ALZpath SIMOA head-to-head comparison. Brain 148(2):408\u2013415","journal-title":"Brain"},{"key":"9322_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-025-00789-3","author":"E Kodosaki","year":"2025","unstructured":"Kodosaki E, Zetterberg H, Heslegrave A (2025) Current methods in clinical Alzheimer\u2019s disease research and diagnosis. Mol Diagn Ther. https:\/\/doi.org\/10.1007\/s40291-025-00789-3","journal-title":"Mol Diagn Ther"},{"issue":"3","key":"9322_CR45","first-page":"271","volume":"78","author":"K Tagai","year":"2026","unstructured":"Tagai K, Tokuda T (2026) Potential of Blood Biomarkers for Early Diagnosis of Dementia. Brain Nerve 78(3):271\u2013275","journal-title":"Brain Nerve"},{"issue":"3","key":"9322_CR46","doi-asserted-by":"publisher","first-page":"e70038","DOI":"10.1002\/alz.70038","volume":"21","author":"J Wang","year":"2025","unstructured":"Wang J, Huang S, Lan G et al (2025) Diagnostic accuracy of plasma p-tau217\/A\u03b242 for Alzheimer\u2019s disease in clinical and community cohorts. Alzheimers Dement 21(3):e70038","journal-title":"Alzheimers Dement"},{"issue":"3","key":"9322_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100472","volume":"13","author":"X Chen","year":"2026","unstructured":"Chen X, Jiang M, Zhang L et al (2026) Association of plasma p-tau and p-tau\/A\u03b2 ratio with Alzheimer\u2019s pathology. J Prev Alzheimers Dis 13(3):100472","journal-title":"J Prev Alzheimers Dis"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09322-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09322-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09322-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:34:23Z","timestamp":1791826463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09322-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["9322"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09322-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.All authors have seen and approved the final version of the manuscript being submitted. They warrant that the article is the authors' original work, hasn't received prior publication and isn't under consideration for publication elsewhere.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"738"}}